0IJO.L
Exelixis, Inc. is a biotechnology firm primarily focused on addressing oncology, dedicated to the discovery, development, and commercialization of innovative therapeutic agents for cancer treatment within the United States. The company markets several key medications. Its product portfolio includes CABOMETYX tablets, prescribed for patients with advanced renal cell carcinoma who have previously undergone anti-angiogenic therapy, and COMETRIQ capsules, utilized in the management of progressive and metastatic medullary thyroid cancer. Both CABOMETYX and COMETRIQ are derived from cabozantinib, a potent inhibitor targeting multiple tyrosine kinases, notably MET, AXL, RET, and VEGF receptors. Add...[Read more]
Industry
Biotechnology
IPO Date
2018-01-29
Stock Exchange
LSE
Ticker
0IJO.L
According to Exelixis, Inc.’s latest financial reports and current stock price. The company's current ROE is 42.49%. This represents a change of 298.55% compared to the average of 10.66% of the last 4 quarters.
The mean historical ROE of Exelixis, Inc. over the last ten years is 14.05%. The current 42.49% ROE has changed 202.48% with respect to the historical average. Over the past ten years (40 quarters), 0IJO.L's ROE was at its highest in in the December 2016 quarter at 39.32%. The ROE was at its lowest in in the September 2016 quarter at -35.24%.
Average
14.05%
Median
14.75%
Minimum
-78.62%
Maximum
54.12%
Discovering the peaks and valleys of Exelixis, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 153.10%
Maximum Annual ROE = 54.12%
Minimum Annual Increase = -168.84%
Minimum Annual ROE = -78.62%
| Year | ROE | Change |
|---|---|---|
| 2026 | 36.21% | 55.89% |
| 2025 | 23.23% | 153.10% |
| 2023 | 9.18% | 25.28% |
| 2022 | 7.33% | -29.92% |
| 2021 | 10.45% | 75.71% |
| 2020 | 5.95% | -68.76% |
| 2019 | 19.04% | -64.48% |
| 2018 | 53.60% | -0.97% |
| 2017 | 54.12% | -168.84% |
| 2016 | -78.62% | -148.31% |
The current ROE of Exelixis, Inc. (0IJO.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
22.87%
5-year avg
17.28%
10-year avg
14.05%
Exelixis, Inc.’s ROE is less than Incyte Corporation (29.70%), less than Rigel Pharmaceuticals, Inc. (96.49%), less than HUTCHMED (China) Limited (1.43%), less than Genmab A/S (13.58%), greater than Revolution Medicines, Inc. (-96.44%), greater than Syndax Pharmaceuticals, Inc. (-372.94%), greater than Curis, Inc. (-1035.26%), less than Ipsen S.A. (11.33%), less than Astellas Pharma Inc. (20.41%), less than AstraZeneca PLC (21.68%),
| Company | ROE | Market cap |
|---|---|---|
| 29.70% | $22.86B | |
| 96.49% | $908.08M | |
| 1.43% | $2.46B | |
| 13.58% | $22.76B | |
| -96.44% | $40.34B | |
| -372.94% | $1.51B | |
| -1035.26% | $1.31M | |
| 11.33% | $53.76B | |
| 20.41% | $25.73B | |
| 21.68% | $246.90B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Exelixis, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Exelixis, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Exelixis, Inc.'s ROE?
How is the ROE calculated for Exelixis, Inc. (0IJO.L)?
What is the highest ROE for Exelixis, Inc. (0IJO.L)?
What is the 3-year average ROE for Exelixis, Inc. (0IJO.L)?
What is the 5-year average ROE for Exelixis, Inc. (0IJO.L)?
How does the current ROE for Exelixis, Inc. (0IJO.L) compare to its historical average?